Content focuses on the financial impact of data management systems on drug development, manufacturing, and distribution; the basic computer system life cycle model and the activities and software quality assurance practices in each phase; and the controls and methods necessary to maintain data integrity and security.
Guidance Documents
Advanced Manufacturing (1)
+Artificial Intelligence (1)
+Commissioning & Qualification (1)
+Data Integrity (16)
+GAMP® (14)
+Knowledge Management (1)
+Pharma 4.0™ (1)
+Quality Assurance (1)
+Regulatory (1)
+Validation (11)
+Community Discussions
Community Discussions
Apr 24, 2025
Validation
Apr 16, 2025
Information Systems
Regulatory
Advanced Manufacturing
Artificial Intelligence
Apr 08, 2025
Data Integrity
Apr 07, 2025
Advanced Manufacturing
Artificial Intelligence
Mar 28, 2025
Information Systems
Regulatory
Advanced Manufacturing
Artificial Intelligence
Mar 20, 2025
Sustainable Facilities, HVAC, & Controlled Environments
Pharmaceutical Engineering Magazine Articles
White Papers
January / February 2025
GAMP® is indispensable for safeguarding the safety, quality, and compliance of pharmaceutical…
January / February 2024
Stakeholders across industries are becoming accustomed to using information technology (IT) systems…
March / April 2022
This article aims to refresh information on open-source software (OSS) within regulated computerized…

Webinars
Upcoming
On-Demand
ISPE in the News
Latest
-
Validation of an Automated Glassware Washer
-
ISPE GAMP® Good Practice Guide: Computerized GCP Systems and Data (Second Edition)
-
ADCs Require Robust Manufacturing Strategies
-
Piramal to Expand in Mich., Ky.
-
BMS to Invest $40B in US Manufacturing, R&D
-
Roche Plans Expansion at Ind. Diagnostics Facility
-
Genentech to Build Manufacturing Facility in N.C.
-
How to Choose Between Freezing, Lyophilizing
-
ISPE Announces Facilities of the Year for 2025
- ISPE Training: Pharma Water Generation USP WFI and Purified Water, Online Live, 13-16 May